This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, G. Articles by Srinivas, H. Search for Related Content PubMed PubMed Citation Articles by Zhang, G. Articles by Srinivas, H.

Estrogen Receptor β Functions through Nongenomic Mechanisms in Lung Cancer Cells

Departments of Pharmacology and Chemical Biology (G.Z., X.L., H.S), Surgery (A.M.F), Pathology (A.V.P), Biostatistics (D.L., S.R.L), and Ophthalmology (K.L.L), University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15213

Address all correspondence and requests for reprints to: Harish Srinivas, University of Pittsburgh Cancer Institute, Hillman Cancer Center, Research Pavilion, Room G.5C, 5117 Centre Avenue, Pittsburgh, Pennsylvania 15213. E-mail: srinivash{at}upmc.edu.

Recent studies have shown that estrogens promote the growth of lung cancer cells and may potentially be responsible for increased susceptibility to lung cancer in women. These observations raise the possibility of using antiestrogens in treating and preventing lung cancer. However, it is not clear how estrogen receptors (ERs) modulate the growth of non-small cell lung cancer (NSCLC) cells. Our Western blotting and real-time PCR analysis showed that NSCLC cells expressed ERβ, but not ER. In addition, ERβ-specific ligands, but not ER-specific ligands, promoted the growth of lung cancer cells. Furthermore, knockdown of ERβ by short hairpin RNA constructs resulted in loss of estrogen-dependent growth of lung cancer cells. Interestingly, endogenous ERβ failed to transcriptionally activate estrogen response element (ERE)-luciferase constructs in NSCLC cells, suggesting a lack of genomic function. Upon further investigation, ERβ was found to be in the cytoplasm in all lung cancer cells and failed to translocate to the nucleus in the presence of estrogen, as observed by biochemical, ArrayScan, and confocal microscopy experiments. Nonetheless, estrogen caused rapid activation of cAMP, Akt, and MAPK signaling pathways in lung cancer cells. Immunohistochemical analysis of lung tumor biopsies showed strong ERβ staining in the cytoplasm, whereas no staining was observed for ER. In conclusion, our results suggest that that proliferative effects of estrogen in lung cancer cells is mediated primarily, if not exclusively, by the nongenomic action of ERβ.

NURSA Molecule Pages Link:

Coregulators:   ERα  |  ERβ

This article has been cited by other articles:

				A. E. Friedman Regarding "Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling" FASEB J, May 1, 2009; 23(5): 1285 - 1286. [Abstract] [Full Text] [PDF]